Mesoporous silica nanoparticles with cyclic peptide gatekeeper for stimulus-responsive drug release by conformational transformation
Source abstract
Abstract
For the preparation of drug delivery vehicles, peptides have been widely adopted due to their valuable bioresponsiveness. In addition, the conformational change of peptides in response to a particular bioenvironment could be adopted as a talented motif for the on-demand release of loaded cargos in mesoporous silica nanoparticles. Here, a cyclic peptide gatekeeper with an intramolecular disulfide bond for on–off triggered gatekeeping and NEWQG sequence for selective binding is prepared. The cyclic peptide gatekeeper conjugated onto the surface of mesoporous silica nanoparticles completely blocks the undesirable leakage of loaded cargos in the pore. Upon treatment of biological reducing agent, the entrapped drugs in the pore of the nanoparticles are released selectively over time by specific reduction of the cystine unit and thereby conformational transformation of the peptide gatekeeper. Graphical abstract
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Chemical Synthesis and Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (39)
Show source-provided references
1. Alberti S, Soler-Illia GJAA, Azzaroni O (2015) Gated supramolecular chemistry in hybrid mesoporous silica nanoarchitectures: controlled delivery and molecular transport in response to chemical, physical and biological stimuli. Chem Commun 51(28):6050–607510.1039/C4CC10414E ↗
2. Aznar E, Oroval M, Pascual L, Murguía JRn, Martínez-Máñez Rn, Sancenón Fl (2016) Gated materials for on-command release of guest molecules. Chem Rev 116(2):561–71810.1021/acs.chemrev.5b00456 ↗
3. Balendiran GK, Dabur R, Fraser D (2004) The role of glutathione in cancer. Cell Biochem Funct 22(6):343–35210.1002/cbf.1149 ↗
4. Coll C, Mondragón L, Martínez-Máñez R, Sancenón F, Marcos MD, Soto J, Amorós P, Pérez-Payá E (2011) Enzyme-mediated controlled release systems by anchoring peptide sequences on mesoporous silica supports. Angew Chem Int Ed 50(9):2138–214010.1002/anie.201004133 ↗
5. Coll C, Bernardos A, Martínez-Máñez R, Sancenón F (2013) Gated silica mesoporous supports for controlled release and signaling applications. Acc Chem Res 46(2):339–34910.1021/ar3001469 ↗
6. Colombo G, Curnis F, De Mori GMS, Gasparri A, Longoni C, Sacchi A, Longhi R, Corti A (2002) Structure-activity relationships of linear and cyclic peptides containing the ngr tumor-homing motif. J Biol Chem 277(49):47891–4789710.1074/jbc.M207500200 ↗
7. Copolovici DM, Langel K, Eriste E, Langel Ü (2014) Cell-penetrating peptides: design, synthesis, and applications. ACS Nano 8(3):1972–199410.1021/nn4057269 ↗
8. Estrela JM, Ortega A, Obrador E (2006) Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 43(2):143–18110.1080/10408360500523878 ↗
9. Fields GB, Noble RL (1990) Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res 35(3):161–21410.1111/j.1399-3011.1990.tb00939.x ↗
10. Kim H, Kim S, Park C, Lee H, Park HJ, Kim C (2010) Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers Adv. Mater 22(38):4280–4283
11. Kresge CT, Leonowicz ME, Roth WJ, Vartuli JC, Beck JS (1992) Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 359(6397):710–71210.1038/359710a0 ↗
12. Lee J, Han S, Lee J, Choi M, Kim C (2017a) Stimuli-responsive α-helical peptide gatekeepers for mesoporous silica nanocarriers. New J Chem 41(15):6969–697210.1039/C7NJ00124J ↗
13. Lee J, Oh E-T, Han Y, Kim HG, Park HJ, Kim C (2017b) Mesoporous silica nanocarriers with cyclic peptide gatekeeper: specific targeting of aminopeptidase n and triggered drug release by stimuli-responsive conformational transformation. Chem Eur J 23(67):16966–1697110.1002/chem.201704309 ↗
14. Lee J, Oh E-T, Song J, Kim HG, Park HJ, Kim C (2017c) Stimulus-induced conformational transformation of cyclic peptide for selective cell targeting on-off gatekeeper of mesoporous nanocarrier. Chem Asian J 12(21):2813–281810.1002/asia.201701050 ↗
15. Lee J, Oh E-T, Choi MH, Kim HG, Park HJ, Kim C (2018) Dual-functional cyclic peptide switch on mesoporous nanocontainers for selective cd44 targeting and on-off gatekeeping triggered by conformational transformation. New J Chem 42(15):12938–1294410.1039/C8NJ02179A ↗
16. Lee J, Oh E-T, Lee J, Kang T, Kim HG, Kang H, Park HJ, Kim C (2019) Cyclic irgd peptide as a dual-functional on-off gatekeeper of mesoporous nanocontainers for targeting nrp-1 and selective drug release triggered by conformational conversion. New J Chem 43(3):1517–152210.1039/C8NJ04649B ↗
17. Lee J, Oh E-T, Yoon H, Kim CW, Han Y, Song J, Jang H, Park HJ, Kim C (2017d) Mesoporous nanocarriers with stimulus-responsive cyclodextrin gatekeeper for targeting tumor hypoxia. Nanoscale 9(20):6901–690910.1039/C7NR00808B ↗
18. Lee J, Kim H, Kim S, Lee H, Kim J, Kim N, Park HJ, Choi EK, Lee JS, Kim C (2012) A multifunctional mesoporous nanocontainer with an iron oxide core and a cyclodextrin gatekeeper for an efficient theranostic platform. J Mater Chem 22(28):14061–1406710.1039/c2jm32137h ↗
19. Lee J, Kim H, Kim C (2016a) Generation dependency of stimuli-responsive dendron-gated mesoporous silica nanocontainers. Macromol Res 24(5):478–48110.1007/s13233-016-4056-y ↗
20. Lee J, Oh E-T, Yoon H, Kim H, Park HJ, Kim C (2016b) A mesoporous nanocontainer gated by stimuli-responsive peptide for selective triggering of intracellular drug release. Nanoscale 8(15):8070–807710.1039/C5NR09280A ↗
21. Lee J, Kim H, Han S, Hong E, Lee K-H, Kim C (2014) Stimuli-responsive conformational conversion of peptide gatekeepers for controlled release of guests from mesoporous silica nanocontainers. J Am Chem Soc 136(37):12880–1288310.1021/ja507767h ↗
22. Li L, Schmitt M, Matzke-Ogi A, Wadhwani P, Orian-Rousseau V, Levkin PA (2017) Cd44v6-peptide functionalized nanoparticles selectively bind to metastatic cancer cells. Adv Sci 4(1):160020210.1002/advs.201600202 ↗
23. Liu H, Wang H, Shenvi S, Hagen TM, Liu R-M (2004) Glutathione metabolism during aging and in alzheimer disease. Ann. N.Y. Acad Sci 1019:346–34910.1196/annals.1297.059 ↗
24. Majhen D, Gabrilovac J, Eloit M, Richardson J, Ambriović-Ristov A (2006) Disulfide bond formation in ngr fiber-modified adenovirus is essential for retargeting to aminopeptidase n. Biochem Biophys Res Commun 348(1):278–28710.1016/j.bbrc.2006.07.051 ↗
25. Matzke A, Herrlich P, Ponta H, Orian-Rousseau V (2005) A five-amino-acid peptide blocks met- and ron-dependent cell migration. Cancer Res 65(14):6105–611010.1158/0008-5472.CAN-05-0207 ↗
26. Matzke-Ogi A, Jannasch K, Shatirishvili M, Fuchs B, Chiblak S, Morton J, Tawk B, Lindner T, Sansom O, Alves F, Warth A, Schwager C, Mier W, Kleeff J, Ponta H, Abdollahi A, Orian-Rousseau V (2016) Inhibition of tumor growth and metastasis in pancreatic cancer models by interference with cd44v6 signaling. Gastroenterology 150(2):513–52510.1053/j.gastro.2015.10.020 ↗
27. Mura S, Nicolas J, Couvreur P (2013) Stimuli-responsive nanocarriers for drug delivery. Nat Mater 12:991–100310.1038/nmat3776 ↗
28. Paris JL, Cabañas MV, Manzano M, Vallet-Regí M (2015) Polymer-grafted mesoporous silica nanoparticles as ultrasound-responsive drug carriers. ACS Nano 9(11):11023–1103310.1021/acsnano.5b04378 ↗
29. Park C, Kim H, Kim S, Kim C (2009) Enzyme responsive nanocontainers with cyclodextrin gatekeepers and synergistic effects in release of guests. J Am Chem Soc 131(46):16614–1661510.1021/ja9061085 ↗
30. Slowing II, Vivero-Escoto JL, Wu C-W, Lin VSY (2008) Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Del Rev 60(11):1278–128810.1016/j.addr.2008.03.012 ↗
31. Tang F, Li L, Chen D (2012) Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater 24(12):1504–153410.1002/adma.201104763 ↗
32. Thornton PD, Heise A (2010) Highly specific dual enzyme-mediated payload release from peptide-coated silica particles. J Am Chem Soc 132:2024–202810.1021/ja9094439 ↗
33. Torre Cdl, Agostini A, Mondragón L, Orzáez M, Sancenón F, Martínez-Máñez R, Marcos MD, Amorós P, Pérez-Payá E (2014) Temperature-controlled release by changes in the secondary structure of peptides anchored onto mesoporous silica supports. Chem Commun 50(24):3184–318610.1039/C3CC49421G ↗
34. Tremmel M, Matzke A, Albrecht I, Laib AM, Olaku V, Ballmer-Hofer K, Christofori G, Héroult M, Augustin HG, Ponta H, Orian-Rousseau V (2009) A cd44v6 peptide reveals a role of cd44 in vegfr-2 signaling and angiogenesis. Blood 114(25):5236–524410.1182/blood-2009-04-219204 ↗
35. Verrier S, Pallu S, Bareille R, Jonczyk A, Meyer J, Dard M, Amédée J (2002) Function of linear and cyclic rgd-containing peptides in osteoprogenitor cells adhesion process. Biomaterials 23(2):585–59610.1016/S0142-9612(01)00145-4 ↗
36. Vivero-Escoto JL, Slowing II, Wu C-W, Lin VSY (2009) Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. J Am Chem Soc 131(10):3462–346310.1021/ja900025f ↗
37. Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VSY (2010) Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 6(18):1952–196710.1002/smll.200901789 ↗
38. Wen J, Yang K, Liu F, Li H, Xu Y, Sun S (2017) Diverse gatekeepers for mesoporous silica nanoparticle based drug delivery systems. Chem Soc Rev 46(19):6024–604510.1039/C7CS00219J ↗
39. Zhang J, Yuan Z-F, Wang Y, Chen W-H, Luo G-F, Cheng S-X, Zhuo R-X, Zhang X-Z (2013) Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery. J Am Chem Soc 135(13):5068–507310.1021/ja312004m ↗